Literature DB >> 17130529

Why is type 1 diabetes uncommon in Asia?

Yongsoo Park1.   

Abstract

T1D (type 1 diabetes) incidence rates are extremely low in Asian populations. The prevalences of islet-specific autoantibodies are reported to be low compared with Caucasians. Although the clinical and immunologic characteristics of T1D in Asians appear to be different from those of Caucasians, if we apply correct patient definition and standardized methods, the typical T1D patients are very similar, in the immunologic as well as genetic perspectives. Although the association of individual allele seems to be different between populations, if we compare the identical DR-DQ haplotypes, the association and transmission to diabetic offspring were similar for Asians and Caucasians. The high-risk HLA genotypes/haplotypes were found to be independent determinants of diabetes in the first-degree relatives of individuals with T1D, particularly in the presence of autoantibodies. A different genetic susceptibility including a low frequency of high-risk HLA alleles could explain the lower prevalence of islet-specific autoantibodies and the low incidence of T1D, or different genetic and environmental interactions might be involved in the etiology of T1D. It is certain that DR-DQ linkage disequilibrium (LD) is an important factor explaining the difference in T1D incidence in different countries. LD between highly susceptible DRB1 alleles and protective DQB1 alleles, and vice versa, is the major contributing factor to the low incidence of T1D in Asians. We also suggested that different genetic/environmental interactions might operate in the etiology of T1D between Caucasians and Asians. It would be of great help for primary prevention to investigate to what degree genetic determinants influence the well-known regional differences in incidences, since we can identify environmental risk factors that may either initiate the autoimmune process or promote already ongoing beta cell damage in different countries. For this, population-based epidemiological studies are necessary to identify risk determinants that may be useful for primary prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130529     DOI: 10.1196/annals.1375.005

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  22 in total

1.  Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.

Authors:  L I Alves; E Davini; M R Correia; R T Fukui; R F Santos; M R Cunha; D M Rocha; W M G Volpini; M E R Silva
Journal:  J Clin Immunol       Date:  2012-03-09       Impact factor: 8.317

2.  Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.

Authors:  Milca Asanghanwa; Frans K Gorus; Ilse Weets; Bart V der Auwera; Folefac Aminkeng; Eric Mbunwe; Patrick Goubert; Katrijn Verhaeghen; Eugene Sobngwi; Janet M Wenzlau; John C Hutton; Daniel G Pipeleers; Bart Keymeulen; Jean-Claude N Mbanya; Chris van Schravendijk
Journal:  Diabetes Res Clin Pract       Date:  2013-11-20       Impact factor: 5.602

3.  Study of factors influencing susceptibility and age at onset of type 1 diabetes: A review of data from Continental Italy and Sardinia.

Authors:  Fulvia Gloria-Bottini; Patrizia Saccucci; Gian Franco Meloni; Maria Luisa Manca-Bitti; Luca Coppeta; Anna Neri; Andrea Magrini; Bottini Egidio
Journal:  World J Diabetes       Date:  2014-08-15

4.  Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.

Authors:  Ban Seok Lee; Eun-Cheol Park; Seung Woo Park; Chung Mo Nam; Jaehoon Roh
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

5.  Outcome after gastrectomy in gastric cancer patients with type 2 diabetes.

Authors:  Jong Won Kim; Jae-Ho Cheong; Woo Jin Hyung; Seung-Ho Choi; Sung Hoon Noh
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

6.  Biomarkers for type 1 diabetes.

Authors:  Sharad Purohit; Jin-Xiong She
Journal:  Int J Clin Exp Med       Date:  2008-02-29

7.  Approaches in type 1 diabetes research: A status report.

Authors:  Oindrila Raha; Subhankar Chowdhury; Samir Dasgupta; P Raychaudhuri; B N Sarkar; P Veer Raju; V R Rao
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

8.  Status and trends of diabetes in Chinese children: analysis of data from 14 medical centers.

Authors:  Jun-Fen Fu; Li Liang; Chun-Xiu Gong; Feng Xiong; Fei-Hong Luo; Ge-Li Liu; Pin Li; Li Liu; Ying Xin; Hui Yao; Lan-Wei Cui; Xing Shi; Yu Yang; Lin-Qi Chen; Hai-Yan Wei
Journal:  World J Pediatr       Date:  2013-05-16       Impact factor: 2.764

Review 9.  Pathophysiologic differences among Asians, native Hawaiians, and other Pacific Islanders and treatment implications.

Authors:  William C Hsu; Edward J Boyko; Wilfred Y Fujimoto; Alka Kanaya; Wahida Karmally; Andrew Karter; George L King; Mele Look; Gertraud Maskarinec; Ranjita Misra; Fahina Tavake-Pasi; Richard Arakaki
Journal:  Diabetes Care       Date:  2012-05       Impact factor: 19.112

10.  A comparison of IDeg + IAsp versus IDet + IAsp in subjects with type 1 diabetes: subgroup analysis of Japanese subjects.

Authors:  Y Ono; T Nishida; J Hyllested-Winge; H Seino; T Sasaki
Journal:  Diabetol Int       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.